Y-mAbs Therapeutics Statistics
Total Valuation
YMAB has a market cap or net worth of $508.60 million. The enterprise value is $434.03 million.
| Market Cap | 508.60M |
| Enterprise Value | 434.03M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
YMAB has 43.88 million shares outstanding. The number of shares has increased by 0.25% in one year.
| Shares Outstanding | 43.88M |
| Shares Change (YoY) | +0.25% |
| Shares Change (QoQ) | +0.35% |
| Owned by Insiders (%) | 12.41% |
| Owned by Institutions (%) | 67.56% |
| Float | 25.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.02 |
| Forward PS | 4.82 |
| PB Ratio | 5.13 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.15, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.15 |
| Quick Ratio | 5.47 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 6.07 |
Financial Efficiency
Return on equity (ROE) is -21.40% and return on invested capital (ROIC) is -24.99%.
| Return on Equity (ROE) | -21.40% |
| Return on Assets (ROA) | -16.90% |
| Return on Capital (ROIC) | -24.99% |
| Revenue Per Employee | $844,990 |
| Profits Per Employee | -$216,660 |
| Employee Count | 100 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 1.32 |
Taxes
In the past 12 months, YMAB has paid $721,000 in taxes.
| Income Tax | 721,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +64.63% in the last 52 weeks. The beta is 0.65, so YMAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | +64.63% |
| 50-Day Moving Average | 12.09 |
| 200-Day Moving Average | 10.99 |
| Relative Strength Index (RSI) | 43.19 |
| Average Volume (20 Days) | 303,859 |
Short Selling Information
The latest short interest is 3.59 million, so 8.17% of the outstanding shares have been sold short.
| Short Interest | 3.59M |
| Short Previous Month | 3.66M |
| Short % of Shares Out | 8.17% |
| Short % of Float | 13.93% |
| Short Ratio (days to cover) | 10.36 |
Income Statement
In the last 12 months, YMAB had revenue of $84.50 million and -$21.67 million in losses. Loss per share was -$0.49.
| Revenue | 84.50M |
| Gross Profit | 73.02M |
| Operating Income | -25.08M |
| Pretax Income | -20.95M |
| Net Income | -21.67M |
| EBITDA | -24.37M |
| EBIT | -25.08M |
| Loss Per Share | -$0.49 |
Balance Sheet
The company has $75.75 million in cash and $1.18 million in debt, giving a net cash position of $74.57 million or $1.70 per share.
| Cash & Cash Equivalents | 75.75M |
| Total Debt | 1.18M |
| Net Cash | 74.57M |
| Net Cash Per Share | $1.70 |
| Equity (Book Value) | 99.19M |
| Book Value Per Share | 2.26 |
| Working Capital | 90.66M |
Cash Flow
| Operating Cash Flow | -17.59M |
| Capital Expenditures | n/a |
| Free Cash Flow | -17.59M |
| FCF Per Share | -$0.40 |
Margins
Gross margin is 86.41%, with operating and profit margins of -29.68% and -25.64%.
| Gross Margin | 86.41% |
| Operating Margin | -29.68% |
| Pretax Margin | -24.79% |
| Profit Margin | -25.64% |
| EBITDA Margin | -28.84% |
| EBIT Margin | -29.68% |
| FCF Margin | -20.81% |
Dividends & Yields
YMAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.25% |
| Shareholder Yield | -0.25% |
| Earnings Yield | -4.26% |
| FCF Yield | -3.46% |
Analyst Forecast
The average price target for YMAB is $19.00, which is 63.93% higher than the current price. The consensus rating is "Buy".
| Price Target | $19.00 |
| Price Target Difference | 63.93% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 24.42% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
YMAB has an Altman Z-Score of 8.28 and a Piotroski F-Score of 4.
| Altman Z-Score | 8.28 |
| Piotroski F-Score | 4 |